Perrigo to release Exalgo generic
DUBLIN, Ireland — Perrigo Co. plc has received approval from the Food and Drug Administration for hydromorphone HCl extended-release tablets 32 mg, an opioid pain medication. Perrigo said it expects to launch its hydromorphone product, a generic verison of Exalgo 32-mg ER tablets from Mallinckrodt, by the end of this month. An opioid agonist, Exalgo
